Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab - Inserm - Institut national de la santé et de la recherche médicale
Article Dans Une Revue Journal of the European Academy of Dermatology and Venereology Année : 2024

Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab

Résumé

Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab

Dear Editor, Discoid lupus (DLE), a subtype of chronic cutaneous lupus erythematosus (CCLE), is the most common CCLE subtype and presents as erythematous, scaly and atrophic plaques of uncovered skin. CCLE may be refractory to conventional therapies, resulting in major aesthetic damage and representing a therapeutic challenge. The pivotal role of type I interferons (IFN-I) in the pathogenesis of systemic

Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-04789301 , version 1 (18-11-2024)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Chloé Grolleau, Thomas Poisot, Jérôme Hadjadj, Marie Jachiet, Thibault Mahevas, et al.. Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab. Journal of the European Academy of Dermatology and Venereology, 2024, ⟨10.1111/jdv.20283⟩. ⟨inserm-04789301⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More